Moreover, pharmacological TRPM2 inhibition was shown to improve insulin sensitivity in adipose tissue during angiotensin II-induced hypertension, suggesting that targeting TRPM2 may be a novel therapeutic strategy to treat hypertension-associated insulin resistance (25). This evidence concerns the gene AGT and hypertensive disorder.